In 2023, the incidence of tuberculosis in China was estimated at 51.0 cases per 100,000 persons. The forecast for 2024 sees a reduction to 50.0, continuing a downward trend over the subsequent years to 45.0 by 2028. This marks an approximate year-on-year decline of 2% from 2024 to 2028. Over the five-year forecast period, the compound annual growth rate (CAGR) reflects a decline rate of approximately 2.5% annually.
Future trends to watch for include advancements in medical technology and healthcare policies in China that could further accelerate the reduction in incidence rates. Monitoring the effectiveness of current TB programs and identifying emerging drug-resistant strains are critical to maintaining this downward trajectory.
